Cargando…
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important therapeutic options in metastatic colorectal cancer (CRC). However, almost all patients with clinical response to anti-EGFR therapies show disease progression wit...
Autores principales: | Mohan, Sumitra, Heitzer, Ellen, Ulz, Peter, Lafer, Ingrid, Lax, Sigurd, Auer, Martina, Pichler, Martin, Gerger, Armin, Eisner, Florian, Hoefler, Gerald, Bauernhofer, Thomas, Geigl, Jochen B., Speicher, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967949/ https://www.ncbi.nlm.nih.gov/pubmed/24676216 http://dx.doi.org/10.1371/journal.pgen.1004271 |
Ejemplares similares
-
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
por: Zhou, Qing, et al.
Publicado: (2020) -
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
por: Ulz, Peter, et al.
Publicado: (2016) -
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
por: Heitzer, Ellen, et al.
Publicado: (2013) -
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma
por: Heitzer, Ellen, et al.
Publicado: (2013) -
The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014)